Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trialRoser Pinyol, Josep M. Llovet, Vincenzo Mazzaferro et al.|Gut|2018Cited by 338
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinomaRobert Montal, Josep M. Llovet, Daniela Sia et al.|Journal of Hepatology|2020Cited by 301
Abstract 4618: Integrative molecular classification of extrahepatic cholangiocarcinomaRobert Montal, Josep M. Llovet, Wei Qiang Leow et al.|Cancer Research|2018Cited by 0